Magne Kristoffer Fagerhol

Magne Kristoffer Fagerhol's AcademicInfluence.com Rankings

Philosophy

#9760

World Rank

#13366

Historical Rank

Logic

#6719

World Rank

#8264

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Magne Kristoffer Fagerhol Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Magne Kristoffer Fagerhol's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin (1990) (524)
Functional and clinical aspects of the myelomonocyte protein calprotectin. (1997) (363)
The polymorphism of “prealbumins” and α1-antitrypsin in human sera (1967) (264)
Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. (1983) (213)
Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. (1985) (184)
Bowel Inflammation as Measured by Fecal Calprotectin (2004) (181)
Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. (1994) (174)
Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration. (2009) (168)
Clinical and laboratory studies (1986) (168)
Calprotectin, a faecal marker of organic gastrointestinal abnormality (2000) (141)
Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. (2012) (141)
Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis (2007) (137)
The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. (1995) (132)
Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. (1987) (131)
Calprotectin inhibits matrix metalloproteinases by sequestration of zinc (2001) (124)
Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen. (1988) (124)
Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978. (1980) (120)
Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma. (1970) (120)
Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism (2002) (118)
Serum Prealbumin: Polymorphism in Man (1965) (114)
Properties of Isolated Human α1‐Antitrypsins of Pi Types M, S and Z (1978) (113)
The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. (1991) (113)
A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. (1980) (113)
Release and Quantitation of a Leucocyte Derived Protein (L1) (2009) (109)
Quantitative Studies on the Inherited Variants of Serum α1-antitrypsin (1969) (104)
The Leucocyte L1 Protein: Identity with the Cystic Fibrosis Antigen and the Calcium‐Binding MRP‐8 and MRP‐14 Macrophage Components (1988) (104)
Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. I. Comparison with other leukocyte markers by paired immunofluorescence and immunoenzyme staining. (1987) (103)
SERU Pi TYPES IN PATIENTS WITH PULMONARY DISEASES (1969) (93)
Age-dependent variations in fecal calprotectin concentrations in children. (2002) (93)
Serum Pi types in Norwegians. (2009) (93)
Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases. (1986) (91)
The Pi system-inherited variants of serum alpha 1-antitrypsin. (1970) (90)
Calprotectin as a marker of inflammation in cystic fibrosis. (1996) (85)
Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. (1984) (84)
Serum Pi types in some European, American, Asian and African populations. (2009) (83)
NEONATAL CHOLESTASIS IN ALPHA‐1‐ANTITRYPSIN DEFICIENT CHILDREN Clinical, Genetic, Histological and Immunohistochemical Findings (1972) (83)
Technology Insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease (2005) (82)
Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity. (1992) (76)
SMOKING AND IMMUNOGLOBULIN LEVELS (1979) (74)
A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. (1989) (72)
The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab (2011) (72)
Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. (2005) (68)
Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14-Toll-like receptor-nuclear factor kappaB pathway. (2003) (67)
The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis. (1991) (63)
Genetics of the Pi serum types. Family studies of the inherited variants of serum alpha-1-antitrypsin. (1969) (59)
Oral contraceptives and low antithrombin-III concentration. (1970) (58)
Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro. (1998) (57)
Effects of Human Calprotectin (L1) on In Vitro Immunoglobulin Synthesis (1994) (52)
The polymorphism of "prealbumins" and alpha-1-antitrypsin in human sera. (1967) (51)
Autosomal linkage between the Gm and Pi loci in man. (1972) (50)
Calprotectin in microglia from frontal cortex is up‐regulated in schizophrenia: evidence for an inflammatory process? (2006) (49)
Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation (1994) (49)
Prenatal genotyping of RHD and SRY using maternal blood (2003) (49)
Faecal calprotectin: a marker of inflammation throughout the intestinal tract (2002) (47)
The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin. (1981) (45)
L1, a major granulocyte protein; isolation of high quantities of its subunits. (1990) (42)
Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. (1993) (41)
Thrombin Generation During Collection and Storage of Blood (1986) (41)
The major leukocyte protein L1 as an indicator of inflammatory joint disease. (1988) (40)
Increase in plasma calprotectin during long‐distance running (2005) (39)
Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein? (1996) (38)
Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events. (1994) (38)
Relationship of neutrophil cytoplasmic protein (L1) to acute and chronic lung disease. (1984) (38)
The Pi Polymorphism (1981) (37)
Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein) (1995) (35)
Leukocyte L1 protein and the cystic fibrosis antigen (1988) (35)
2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase. (1972) (35)
Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: effect of inhaled glucocorticoid therapy. (2002) (34)
Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils. (2004) (34)
Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease. (1990) (33)
Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex. (2009) (33)
Serum Pi types in some Lappish and Finnish populations. (1969) (33)
L1, a major granulocyte protein: antigenic properties of its subunits. (1988) (31)
Properties of isolated human alpha1-antitrypsins of Pi types M, S and Z. (1978) (28)
The Pi Phenotype MP (1968) (28)
The effect of intestinal colonization of germ-free pigs with Escherichia coli on calprotectin levels in plasma, intestinal and bronchoalveolar lavages. (2005) (28)
Calprotectin plasma level is elevated in preeclampsia (2005) (26)
Increased circulating levels of alpha1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs. (2001) (25)
ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations. (2003) (25)
Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass. (1994) (25)
Calprotectin in cerebrospinal fluid of the HIV infected: a diagnostic marker of opportunistic central nervous system infection? (1991) (24)
Severe Anemia and Neutropenia Associated With Hyperzincemia and Hypercalprotectinemia (2005) (24)
Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis (2018) (24)
Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo. (1979) (23)
Studies on Coagulation and Fibrinolysis in Pregnancy (1975) (23)
Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary. (2008) (23)
Components of the kallikrein-kinin system and the spontaneous cold activation of factor VII in human plasma. (2009) (23)
Quantitative studies on the inherited variants of serum alpha-1-antitrypsin. (1969) (22)
QUANTITATION OF A LEUKOCYTE PROTEIN (L1) IN URINE (1983) (22)
Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis (2009) (21)
The genetics of alpha-1-antitrypsin and its implications. (1976) (21)
Major operations, hemostatic parameters and venous thrombosis. (1974) (21)
Improved estimate of the Gm‐Pi linkage (1975) (21)
Cardiac surgery and distribution of the leukocyte L1 protein-calprotectin. (1991) (19)
Additional evidence for a deleted gene for serum alpha-1-antitrypsin. (1973) (19)
Changes in antithrombin 3 levels following cessation of anticoagulant therapy. (2009) (17)
Protease inhibitor (Pi) phenotypes in chromosome aberrations. (1970) (17)
The effect of pre-storage cooling on 2,3-DPG levels in red cells stored in SAG-M. (2005) (16)
Quantitation of a highly immunogenic leukocyte antigen (L1) by radioimmunoassay: methodological evaluation. (1983) (16)
Purification of human factor IX. (1977) (16)
Antithrombin-III concentration and ABO blood-groups (1971) (15)
Decreased Fc-receptor binding in human monocytes exposed to ethanol in vitro. (1985) (15)
Report of nomenclature meeting for α1-antitrypsin (2004) (14)
Calprotectin (the L1 protein) during surgery in patients with rheumatoid arthritis. (1991) (13)
Pi Typing Techniques (1975) (13)
Calprotectin and complement activation during major operations with or without cardiopulmonary bypass. (1993) (13)
The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab (2014) (13)
Bacteria in the Adventitia of Cardiovascular Disease Patients with and without Rheumatoid Arthritis (2014) (12)
The Pi phenotype MP. Discovery of a ninth allele belonging to the system of inherited variants of serum alpha 1 antitrypsin. (1968) (11)
Pi phenotypes in patients with ankylosing spondylitis, acute anterior uveitis, psoriasis and chronic prostatitis (1984) (9)
Large molecular size EDTA-resistant complexes containing S100A12, ERAC, in serum during inflammatory conditions (2012) (9)
Tracing the leukocyte marker protein in lung fluids and lung-draining lymph nodes during endotoxemia in sheep. (1986) (8)
Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII. (2009) (7)
PiPclifton: a new α1-antitrypsin allele in an American Negro family* (1981) (7)
Concentration of Antithrombin III During Combined and Progestogen‐Only Oral Contraceptive Treatment (1972) (7)
FAECAL CALPROTECTIN: A NON INVASIVE MARKER OF INFLAMMATION IN PIGS? (2005) (7)
Sixteen years of plasma exchange in a homozygote for familial hypercholesterolaemia (1993) (7)
Antithrombin 3 concentration in women using low-dosage progestogen for contraception. (1972) (7)
PiEcincinnati: A new alpha1-antitrypsin allele in three negro families (2004) (6)
Classification of human serum prealbumins after starch gel electrophoresis. (1966) (6)
Alpha‐1‐antitrypsin (Pi)‐types in recurrent miscarriages (1978) (6)
STUDIES ON COAGULATION AND FIBRINOLYSLS IN BLOOD FROM PUERPERAL WOMEN WITH AND WITHOUT OESTROGEN TREATMENT (1975) (6)
Contaminating fibrin in CPD-blood: solubility in plasma and distribution in blood components following separation. (1986) (6)
Effect of estrogen treatment on coagulation and fibrinolysis in postmenopausal women. With special reference to cold activation of factor VII. (1978) (5)
Levels of calprotectin (leukocyte L1 protein) during apheresis. (1992) (5)
NETs analysed by novel calprotectin‐based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: A pilot study (2020) (5)
Albumin and transferrin variants in Norwegians. (2009) (5)
Heterogeneity of the Human Haptoglobin 1‐1 Molecule by Electrophoresis of Serum in Starch Gels at pH 4.9 (1969) (4)
Lack of Anti-A Hæmagglutinin Response to Influenza Infection (1964) (4)
Letter: First International Alpha-Antitrypsin Pi System Workshop. (1975) (3)
PiPclifton: a new alpha 1-antitrypsin allele in an American Negro family. (1981) (3)
Immunoelectrophoretic quantitation of antithrombin III. Electroimmunodiffusion in agarose gels containing heparin. (2009) (3)
α‐Fetoprotein: A Marker for Threatened Abortion (1979) (3)
[Hepatitis associated antigen (HAA) and the blood transfusion. A follow-up study of recipients of blood from donors with HAA and antibody]. (1971) (3)
[Plasma calprotectin. A new prognostic marker of survival in alcoholic liver cirrhosis]. (1996) (3)
PiZpratt: A new alpha1-antitrypsin allele in an American negro family (1980) (3)
Lack of ABO isoagglutinin response to influenza A2 infection. (1965) (3)
Plasma exchange in two "receptor negative" homozygotes for autosomal, dominant hypercholesterolemia. (1982) (2)
P029 A New ‘Calprotectin POC Device’ Correlates With Elisa and Separates Between Endoscopic Assessed Mucosal Healing and Active Ulcerative Colitis (2007) (2)
A Strong Antibody Reacting with Enzyme Modified E Positive Red Blood Cells (1979) (2)
Heterogeneity of the Haptoglobin 1–1 Molecule by Electrophoresis of Human Serum in Starch Gels at pH 4.9 (1970) (2)
Alpha‐Fetoprotein Concentration in Maternal Serum and Abortion via VA and PGF2α (1978) (2)
Release of interleukin-8 and calprotectin during and after paediatric cardiopulmonary bypass with and without ultrafiltration. (1996) (2)
Isolation and partial characterisation of a new antiproliferative substance from human leucocytes inhibiting growth of Candida albicans (2003) (1)
1192 FCINCINNATI: A NEW ALPHA1-ANTITRYPSIN VARIANT IN TWO NEGRO FAMILIES (1978) (1)
Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors (2022) (1)
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects (2022) (1)
Severe toxic reaction to tinidazole (2004) (1)
Changes in calprotectin concentration in sow's milk throughout lactation. (2007) (1)
myelomonocyte protein calprotectin (1)
Low antithrombin in severe disease: Consumption or decreased synthesis? (2009) (0)
[Neonatal cholestasis and deficiency of alpha-1-antitrypsin (author's transl)]. (1974) (0)
Pure pI 6.3 and pI 6.5 L1 protein, their methods of preparation and use thereof (1984) (0)
Human proteins, methods for their preparation and test kits containing them (1984) (0)
First International Alpha1-Antitrypsin Pi System Workshop (2015) (0)
Improvement in Aortic Stiffness After one Year of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Arthropathies is Associated with Reduction in Calprotectin (A Proinflammatory S100 Protein) (2009) (0)
Antithrombin-3 concentration and ABO blood-groups. (1971) (0)
[ELDON CARDS FOR THE LAST TIME]. (1964) (0)
Identification of the zinc binding protein in a child with hyperzincaemia as calprotectin (MRP8/MRP14) (2002) (0)
[Alpha-1-antitrypsin deficiency in a patient with mucoviscidosis]. (1973) (0)
[Blood supply readiness in case of war or disasters]. (1999) (0)
The use of the Rome criteria and surrogate markers of inflammation to distinguish organic from non organic intestinal disease. (2000) (0)
arthritisand damage in rheumatoid joint strongly and independently correlated with Calprotectin (a major leucocyte protein) is (2010) (0)
[Antithrombin 3 concentration in the blood]. (1970) (0)
Alpha-fetoprotein: a marker for threatened abortion. (1978) (0)
PiPcliflon: a new ai-antitrypsin allele inan American Negrofamily* (2017) (0)
The use of mono-specific anti-L1 antisera and monospecific anti-L1 antibodies to qualitatively or quantitatively determine meles of L1 proteins in cells, tissues, or body fluids, as well as test equipment containing them (1984) (0)
[DETERMINATION OF BLOOD GROUPS IN BLOOD DONORS IN NORWEGIAN HOSPITALS. OCCURRENCE OF TYPING ERRORS IN THE YEARS 1961-63]. (1964) (0)
Faecal calprotectin concentrations in patients with colorectal cancer or inflammatory bowel disease (0)
Calcium binding andconcomitant changes in thestructure andheatstability ofcalprotectin (LIprotein) (1995) (0)
[ERRONEOUS TYPING WITH THE ELDON CARD]. (1965) (0)
A process for the extraction of the proteins (1997) (0)
Oral contraceptives and low antithrombin-3 concentration. (1970) (0)
[Can the measurement of antithrombin-3 point out women who run the risk of thrombosis with the use of P-pills?]. (1970) (0)
The Gm-Pi linkage: a summary estimate. (1975) (0)
[AIDS testing on a large scale is needed in the fight against the epidemic]. (1988) (0)
Subject Index Vol. 22, 1978 (1978) (0)
References to the committee reports (1975) (0)
[The Pi system, its genetics and its relations with diseases]. (1971) (0)
[Should oral contraceptives be discontinued before surgery or during illness?]. (1971) (0)
IMPROVEMENT IN AORTIC STIFFNESS DURING ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES IS ASSOCIATED WITH REDUCTION IN CALPROTECTIN: 3A.05 (2010) (0)
DNase analyzed by a novel competitive assay in patients with complications after ChAdOx1 nCoV ‐19 vaccination and in normal unvaccinated blood donors (2023) (0)
Alpha-1-antitrypsin deficiency in pulmonary and liver degeneration. (1974) (0)
Leukocyte l 1 antigen in pulmonary lymphatic tissue and pulmonary lymph of endotoxin treated sheep (1985) (0)
Erratum to: The Pi Polymorphism (1981) (0)
Pi (antitrypsin) typing methods. A comparison of acid starch-gel electrophoresis and isoelectric focusing. (1977) (0)
Faecal Calprotectin: A Link between Lifestyle and Colonic Neoplasia Risk (2002) (0)
The allergy tests "RIST" and "RAST" in evaluation of allergy in children below two years of age. (1976) (0)
Neutrophil Turnover in Chronic Obstructive Bronchitis and other Lung Diseases (1982) (0)
Repolarization, effects of drugs /Leucocyte activation in acute coronary syndromes 429 2332 Lack of the reverse use-dependent 'effect of the class-Ill antlarrhythmk: drug' d-sotalol on the guinea pig eplcardlum (2004) (0)
FRI0138 S100A12 and Calprotectin in Serum and The Aorta of Patients with Cardiovascular Disease and Inflammatory Rheumatic Disease: A Biopsy Study (2016) (0)
[Fetomaternal hemorrhage]. (1983) (0)
Regional chromosome 12 mapping: information from a family with a (12;21) reciprocal translocation. (1978) (0)
The Gm-Pi linkage: a summary estimate. (1975) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Magne Kristoffer Fagerhol?

Magne Kristoffer Fagerhol is affiliated with the following schools:

University of Oslo

Magne Kristoffer Fagerhol's Academic­Influence.com Rankings

Why Is Magne Kristoffer Fagerhol Influential?

Magne Kristoffer Fagerhol's Published Works

Published Works

What Schools Are Affiliated With Magne Kristoffer Fagerhol?

Magne Kristoffer Fagerhol's AcademicInfluence.com Rankings